In brief
Published on 22 January 2025
The Agence de la biomédecine collects, analyzes and publishes consolidated data for all its areas of intervention in its annual medical and scientific reports. These reports are essential for monitoring practices, assessing developments and improving the quality of care. They are essential decision-making tools for healthcare professionals and regulatory authorities.
Data collected for a global view of activities
The data consolidated and analyzed by the agency are compiled in annual medical and scientific reports. They concern organ and tissue procurement and transplantation, the Réseau Epidémiologie Information Néphrologie (R.E.I.N.), hematopoietic stem cell procurement and transplantation, medically assisted procreation, pre-implantation diagnosis, prenatal diagnosis and post-natal genetics. They include individual data, enabling precise tracking of patient or donor paths, and aggregated data, summarizing activity volumes to provide an overview of medical practices.
In-depth analysis for quality and safety
The Agence de la biomédecine also publishes a report dedicated to vigilance, quality and health safety for several of the activities it oversees: medically assisted procreation, organ and tissue removal and transplantation, hematopoietic stem cell removal and transplantation, and breast milk. This information is used to monitor adverse events, assess practices and identify areas for improvement. By sharing these results with healthcare professionals, researchers and decision-makers, the agency contributes to the continuous improvement of medical practices, patient safety and, more generally, the quality of care.
Further information
Share